Amiodarone-induced thyroid dysfunction.
Porsche
Renate
R
Westfall Cardiology, Rochester Heart Institute, Rochester General Hospital, NY, USA.
Brenner
Zara R
ZR
D000368:Aged; D000638:Amiodarone / Q000009:adverse effects* / Q000378:metabolism / Q000493:pharmacokinetics; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000378:metabolism / Q000493:pharmacokinetics; D001281:Atrial Fibrillation / Q000188:drug therapy; D003422:Critical Care / Q000379:methods*; D003937:Diagnosis, Differential; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D008297:Male; D008657:Metabolic Clearance Rate; D008991:Monitoring, Physiologic / Q000451:nursing; D024802:Nurse's Role; D009730:Nursing Assessment; D010351:Patient Discharge; D010353:Patient Education as Topic; D012016:Reference Values; D013960:Thyroid Function Tests / Q000379:methods; D013963:Thyroid Hormones / Q000502:physiology; D013971:Thyrotoxicosis / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy
D000889:Anti-Arrhythmia Agents; D013963:Thyroid Hormones; D000638:Amiodarone